Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

First Patient Dosed in Study Assessing Immunotherapy in Metastatic Breast Cancer

November 30th 2024, 3:00pm

Article

The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in metastatic breast cancer.

Phase 2 Study Assessing Alisertib in Metastatic Breast Cancer Subset Begins

November 28th 2024, 4:00pm

Article

A phase 2 study for patients with HR-positive, HER2-negative metastatic breast cancer will be evaluating alisertib plus endocrine therapy.

Overcoming Hormone Therapy Resistance in Metastatic Breast Cancer

November 27th 2024, 4:00pm

Video

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to hormone therapy.

Itovebi Combo May Improve Survival in Metastatic Breast Cancer Subtype

November 26th 2024, 8:00pm

Article

An Itovebi regimen demonstrated significantly longer progression-free survival compared with placebo in some with metastatic breast cancer.

Trodelvy Is Effective in Real-World Patients With Breast Cancer Subset

October 24th 2024, 7:13pm

Article

Trodelvy shows effectiveness in real-world breast cancer treatment, even after receiving Enhertu therapy.

‘Not Enough to Say Breast Cancer’ When Discussing Diagnoses, Expert Says

October 21st 2024, 1:00pm

Video

An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.

Biomarkers Guide Treatment for Metastatic Breast Cancer

October 15th 2024, 3:00pm

Article

An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.

FDA Approves Itovebi Combo for Some With Advanced Breast Cancer

October 10th 2024, 8:13pm

Article

The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer.

Being Unprepared May Open The Door To Life-Changing Lessons With Stage 4 Cancer

October 9th 2024, 5:00pm

Article

Martha Carlson shares her experience of overcoming her fears and embarking on a whitewater rafting adventure despite her stage 4 cancer diagnosis.

Side Effects, Quality of Life Important to Consider in Breast Cancer Subset

September 29th 2024, 3:00pm

Article

Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.